title: Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons.
abstract: Hippocampal CA1 homosynaptic long-term potentiation (LTP) is expressed specifically at activated synapses. Increased insertion of postsynaptic alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptors (AMPARs) appears to be crucial for CA1 LTP. However, the mechanism underlying AMPAR insertion during LTP remains largely unknown. We now report that phosphatidylinositol 3-kinase (PI3K) is complexed with AMPARs at synapses and activated by selective stimulation of synaptic N-methyl-D-aspartate (NMDA) receptors. Activation of the AMPAR-associated PI3K is required for the increased cell surface expression of AMPARs and LTP. Thus, our results strongly suggest that the AMPAR-PI3K complex may constitute a critical molecular signal responsible for AMPAR insertion at activated CA1 synapses during LTP, and consequently, this lipid kinase may serve to determine the polarity of NMDA receptor-dependent synaptic plasticity.
authors.affiliation: Brain and Behavior Program and Department of Pathology, Research Institute of the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5S 1A8.
authors.forename: Heng-Ye
authors.initials: HY
authors.lastname: Man
authors.forename: Qinhua
authors.initials: Q
authors.lastname: Wang
authors.forename: Wei-Yang
authors.initials: WY
authors.lastname: Lu
authors.forename: William
authors.initials: W
authors.lastname: Ju
authors.forename: Gholamreza
authors.initials: G
authors.lastname: Ahmadian
authors.forename: Lidong
authors.initials: L
authors.lastname: Liu
authors.forename: Sandra
authors.initials: S
authors.lastname: D'Souza
authors.forename: T P
authors.initials: TP
authors.lastname: Wong
authors.forename: C
authors.initials: C
authors.lastname: Taghibiglou
authors.forename: Jie
authors.initials: J
authors.lastname: Lu
authors.forename: Larry E
authors.initials: LE
authors.lastname: Becker
authors.forename: Lin
authors.initials: L
authors.lastname: Pei
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.forename: Matthias P
authors.initials: MP
authors.lastname: Wymann
authors.forename: John F
authors.initials: JF
authors.lastname: MacDonald
authors.forename: Yu Tian
authors.initials: YT
authors.lastname: Wang
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D002867:Chromones / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000166:cytology*; D017774:Long-Term Potentiation / Q000502:physiology*; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D009473:Neuronal Plasticity / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D021381:Protein Transport / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D000077191:Wortmannin
chemical_list: D000730:Androstadienes; D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D018091:Receptors, AMPA; D000077191:Wortmannin; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one